The US Food and Drug Administration (FDA) has approved oveporexton (ORZEYFUL) for adults with narcolepsy type 1 (NT1), making it the first approved treatment designed to address the underlying orexin deficiency associated with the condition. NT1 is a rare, chronic neurological disorder characterised by loss of orexin signalling. It can cause excessive daytime sleepiness, cataplexy,…
Category: Industry News
Fampridine recommended for use in England
NHS England has recommended fampridine for routine use in adults with multiple sclerosis (MS), improving access to the only licensed medicine shown to enhance walking ability in eligible patients. The decision, announced on 17 July 2026, follows years of campaigning and is expected to broaden access as generic versions become available after the expiry of…
Choose Neurology
People are often frightened of neurological conditions, and that goes for clinicians as well as patients! Neurophobia is well documented among medical students and non-neurologist doctors. Neurology is often perceived as complex and intimidating. Project Neurology was launched with the goal of tackling Neurophobia among (primarily) students, trainees and early career doctors. However, what started…
Peppermint oil shows potential to lower blood pressure in new study
Researchers at the University of Lancashire have reported that peppermint oil may offer a simple and inexpensive way to reduce mildly elevated blood pressure, following the results of a new clinical study published in PLOS One. The study found that participants who consumed 100 microlitres of peppermint oil twice daily for 20 days experienced an…
AbbVie’s AQUIPTA® (atogepant) is recommended by NICE as an option for the acute treatment of migraine in adults
• The National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance (FDG) recommending AQUIPTA® (atogepant), an oral tablet, as an option for the acute treatment of migraine with or without aura in adults, only if, for previous migraines: at least two triptans were tried and they did not work well enough,…
Landmark £1.4 million programme aims to strengthen clinical academic careers across northern England
A new £1.4 million initiative designed to support clinical researchers and future research leaders across the North of England has secured funding from the Medical Research Council (MRC). The programme, known as Building Translational Research Excellence Among Clinicians of the North (BEACON), will provide career development opportunities, flexible funding and collaborative networks for clinicians pursuing…
New website aims to support exercise for people with long-term conditions
A new public health initiative called Moving Medicine for Everybody has launched in the UK to provide practical, evidence-based advice on physical activity for people living with long-term health conditions. The platform is designed to help patients and healthcare professionals incorporate movement into everyday care, with a focus on reducing barriers for those who may…
Professor Andrew Dick appointed as Dean of Brain Sciences
Professor Andrew Dick has been appointed as the next Dean of the UCL Faculty of Brain Sciences, taking up the role in September 2026. A leading specialist in eye disease and ocular immunology, he succeeds Professor Alan Thompson, who has served as Dean since the faculty was established in 2011. Professor Dick currently holds the…
MS cases rise in England as survival improves but inequalities remain
Multiple sclerosis diagnoses have increased significantly in England over the past two decades, while advances in care and earlier diagnosis have improved survival rates. However, new research highlights that social inequalities continue to influence outcomes, with people in more deprived areas facing higher mortality. The study, led by researchers at University College London and published…
How gut bacteria could trigger memory loss as we age
Scientists are uncovering new evidence that changes in gut bacteria may play a direct role in age-related memory loss. A recent study published in Nature by researchers at the Arc Institute in California suggests that specific microbes in the gut could influence brain function through immune and neural pathways. The research team, led by Christoph…
